Home/Filings/4/0001179110-20-005307
4//SEC Filing

YOUNG WILLIAM D 4

Accession 0001179110-20-005307

CIK 0001583107other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 7:09 PM ET

Size

6.8 KB

Accession

0001179110-20-005307

Insider Transaction Report

Form 4
Period: 2020-04-28
Transactions
  • Award

    Ordinary Shares

    2020-04-28+6,63558,330 total
  • Award

    Share Option (Right to Buy)

    2020-04-28+6,0006,000 total
    Exercise: $30.14Exp: 2030-04-27Ordinary Shares (6,000 underlying)
Footnotes (1)
  • [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001217420

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 7:09 PM ET
Size
6.8 KB